Cycle Pharmaceuticals Selects LeMed Specialty Pharmacy as Exclusive U.S. Specialty Pharmacy Distribution and Services Partner for HARLIKU™ (nitisinone) Tablets —the First and only FDA-approved Treatment for Reducing Urinary Homogentisic Acid (HGA) in Adult Patients with Alkaptonuria (AKU)